Fresenius Medical Care AG & Co. KGaA
FMSNYSEHealthcare● Active
$21.79
$-0.24(-1.09%)
Market Cap$11.7B
P/E Ratio—
52W High$29.07
52W Low$20.02
Fresenius Medical Care AG & Co. KGaA (FMS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FMS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.94B | $0.74B | $0.73B | $0.89B | $1.22B |
| Depreciation & Amort. | $1.41B | $1.74B | $1.75B | $1.84B | $1.62B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.03B | $0.00B | $0.00B |
| Change in Working Capital | $0.13B | $0.44B | $0.56B | ($0.13B) | ($0.10B) |
| Net Cash from Operations | $2.58B | $2.39B | $2.63B | $2.17B | $2.49B |
| Investing Activities | |||||
| Capital Expenditure | ($0.88B) | ($0.70B) | ($0.68B) | ($0.72B) | ($0.85B) |
| Purchases of Investments | ($0.09B) | ($0.08B) | ($0.10B) | ($0.11B) | ($0.13B) |
| Sales of Investments | $0.08B | $0.08B | $0.09B | $0.06B | $0.14B |
| Net Cash from Investing | ($0.67B) | ($0.08B) | ($0.54B) | ($0.73B) | ($1.20B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.56B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.41B) | ($0.35B) | ($0.33B) | ($0.40B) | ($0.39B) |
| Debt Issued / Repaid | $0.77B | ($1.91B) | ($1.19B) | ($1.12B) | ($0.36B) |
| Net Cash from Financing | ($1.38B) | ($2.57B) | ($1.86B) | ($1.62B) | ($1.02B) |
| Free Cash Flow | |||||
| Free Cash Flow | $1.70B | $1.69B | $1.94B | $1.44B | $1.64B |
| FCF Margin %(computed) | 8.64% | 8.72% | 9.99% | 7.44% | 9.28% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B
Explore more Fresenius Medical Care AG & Co. KGaA data
About Fresenius Medical Care AG & Co. KGaA (FMS) Cash Flow Statement
Fresenius Medical Care AG & Co. KGaA generated operating cash flow of $2.58B and free cash flow of $1.70B for 2025 — a FCF margin of 8.64%. Capital expenditure was ($0.88B).
Frequently asked questions
FMS · 4 questionsFresenius Medical Care AG & Co. KGaA generated free cash flow of $1.70B for 2025, up 0.5% year-over-year.
FMS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10